Follow the 온코닉테라퓨틱스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 온코닉테라퓨틱스 has logged 30 insider filings. Market capitalisation: €504.5bn. The latest transaction was reported on 3 July 2026 (Sale). Among the most active insiders: 신종길. Every trade is openly available.
30
Insider Decl.
n/a
Thresholds
€205,917
24 ops.
Buy Volume
€8m
4 ops.
Sell Volume
22Σ signal
Buys €205,917€8m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,803 of 28,199 companies
64.5
score / 100
Value
34
Quality
95
FCF yld1.8%
Earn yld2.5%
EV/EBITDA44.2x
ROE29%
Gross mgn100%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Onconic Therapeutics is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.